These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10639615)

  • 1. Malignant hyperthermia: fatigue characteristics of skeletal muscle.
    Balog EM; Enzmann NR; Gallant EM
    Muscle Nerve; 2000 Feb; 23(2):223-30. PubMed ID: 10639615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porcine malignant hyperthermia: halothane effects on force generation in skeletal muscles.
    Gallant EM; Goettl VM
    Muscle Nerve; 1989 Jan; 12(1):56-63. PubMed ID: 2747737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered mechanical responses of malignant hyperthermic skeletal muscle during repetitive stimulation.
    Williams JH; Holland M; Ward CW; Lee JC
    J Physiol Paris; 1992; 86(4):159-65. PubMed ID: 1343601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal action potential responses to halothane in heart muscle isolated from malignant hyperthermia-susceptible pigs.
    Roewer N; Greim C; Rumberger E; Schulte am Esch J
    Anesthesiology; 1995 Apr; 82(4):947-53. PubMed ID: 7717567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The action of perchlorate on malignant-hyperthermia-susceptible muscle.
    Anderson LC; Fruen BR; Jordan RC; Louis CF; Gallant EM
    Pflugers Arch; 1997 Dec; 435(1):91-8. PubMed ID: 9359907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effects of levosimendan on muscle of malignant hyperthermia susceptible and non-susceptible swine.
    Schuster F; Johannsen S; Isbary S; Türkmeneli I; Roewer N
    BMC Anesthesiol; 2018 Dec; 18(1):182. PubMed ID: 30509180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of serotonin 2 receptor agonists on skeletal muscle preparations in patients with a disposition toward malignant hyperthermia].
    Wappler F; Roewer N; Köchling A; Scholz J; Steinfath M; Rumberger E; Löscher W; Schulte am Esch J
    Anaesthesist; 1995 Aug; 44(8):538-44. PubMed ID: 7573901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase-III-inhibition with amrinone leads to contracture development in skeletal muscle preparations of malignant hyperthermia susceptible swine.
    Fiege M; Wappler F; Weisshorn R; Gerbershagen MU; Kolodzie K; Schulte am Esch J
    Eur J Anaesthesiol; 2005 Apr; 22(4):283-8. PubMed ID: 15892406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in ryanodine-induced contractures by stimulus frequency in malignant hyperthermia susceptible and malignant hyperthermia nonsusceptible dog skeletal muscle.
    Sudo RT; Nelson TE
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1331-6. PubMed ID: 9316843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porcine malignant hyperthermia: cell injury enhances halothane sensitivity of biopsies.
    Gallant EM; Fletcher TF; Goettl VM; Rempel WE
    Muscle Nerve; 1986 Feb; 9(2):174-84. PubMed ID: 3951491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant hyperthermia: effects of sarcoplasmic reticulum Ca2+ pump inhibition.
    Enzmann NR; Balog EM; Gallant EM
    Muscle Nerve; 1998 Mar; 21(3):361-6. PubMed ID: 9486865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ritanserin attenuates the in vitro effects of the 5-HT2 receptor agonist DOI on skeletal muscles from malignant hyperthermia-susceptible patients.
    Wappler F; Scholz J; Oppermann S; von Richthofen V; Steinfath M; Schulte am Esch J
    J Clin Anesth; 1997 Jun; 9(4):306-11. PubMed ID: 9195354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
    McCarthy TV; Quane KA; Lynch PJ
    Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [4-chloro-m-cresol-induced contractures of skeletal muscle specimen from patients at risk for malignant hyperthermia].
    Wappler F; Scholz J; von Richthofen V; Fiege M; Steinfath M; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Sep; 32(9):541-8. PubMed ID: 9417254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Excitation-contraction coupling in pigs heterozygous for malignant hyperthermia.
    Gallant EM; Lentz LR
    Am J Physiol; 1992 Feb; 262(2 Pt 1):C422-6. PubMed ID: 1539630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voltage-dependent calcium release in human malignant hyperthermia muscle fibers.
    Struk A; Lehmann-Horn F; Melzer W
    Biophys J; 1998 Nov; 75(5):2402-10. PubMed ID: 9788935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of chlorocresol vs caffeine on muscle contracture in malignant hyperthermia susceptible patients].
    Ben-Abraham R; Krivosic-Horber RM; Haudcoeur G; Perel A; Adnet PJ
    Harefuah; 1997 Jun; 132(12):839-41, 911. PubMed ID: 9264187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypersensitivity of malignant hyperthermia-susceptible swine skeletal muscle to caffeine is mediated by high resting myoplasmic [Ca2+ ].
    López JR; Contreras J; Linares N; Allen PD
    Anesthesiology; 2000 Jun; 92(6):1799-806. PubMed ID: 10839932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis of susceptibility to malignant hyperthermia with an in vitro contracture test with the phosphodiesterase iii inhibitor enoximone].
    Fiege M; Wappler F; Scholz J; von Richthofen V; Brinken B; Schulte am Esch J
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1998 Sep; 33(9):557-63. PubMed ID: 9787864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins alter intracellular calcium homeostasis in malignant hyperthermia susceptible individuals.
    Metterlein T; Schuster F; Tadda L; Hager M; Roewer N; Anetseder M
    Cardiovasc Ther; 2010 Dec; 28(6):356-60. PubMed ID: 20955541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.